Furthermore, to determine whether AKT/NF-κB signaling pathway is responsible for iCAFs’ effect on cell migration and invasion, lung cancer cells were pretreated with either AKT inhibitor perifosine or NF-κB inhibitor JSH23 and then cultured in iCAFs-CM. The gene discussed is NFKB1; the disease is lung carcinoma.